Allspring Global Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Allspring Global Investments's PFE Position: Q1 2026 in Review
Allspring Global Investments reduced its Pfizer (PFE) stake by 28% in Q1 2026, selling an estimated $6.44M and leaving 620,597 shares worth $17.7M. The position accounts for 0.03% of the portfolio, ranked #559.
Allspring Global Investments first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $262M in Q4 2021. 2,947 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Allspring Global Investments held 620,597 shares of Pfizer worth $17.7M as of Q1 2026.
- Allspring Global Investments sold 241,954 Pfizer shares in Q1 2026, an estimated $6.44M.
- Pfizer made up 0.03% of Allspring Global Investments's portfolio in Q1 2026, its #559 holding.
- Allspring Global Investments first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- Allspring Global Investments's Pfizer position peaked at $262M in Q4 2021.
- 2,947 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.